IGHE and Alzheimer disease: In the acute phase of AD, an abnormal Th2 cell immune response induces elevated levels of immunoglobulin E (IgE) and infiltration of AD effector cells, thereby potentially aggravating the disease and triggering a systemic Th2 cell response.11